# FDA Inspection 1309464 - Fougera Pharmaceuticals, Inc. - March 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/fougera-pharmaceuticals-inc/0a2352b7-37fb-4c97-801b-4cfa3f327b63
Source feed: FDA_Inspections

> FDA Inspection 1309464 for Fougera Pharmaceuticals, Inc. on March 26, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309464
- Company Name: Fougera Pharmaceuticals, Inc.
- Inspection Date: 2026-03-26
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1309464 - 2026-03-26](https://www.keypedia.com/records/fda_inspections/fougera-pharmaceuticals-inc/704d5ca7-4d46-4438-940b-2bbcd6a2977c)
- [FDA Inspection 1309464 - 2026-03-26](https://www.keypedia.com/records/fda_inspections/fougera-pharmaceuticals-inc/a1c5d4f4-a178-4858-8c00-335f2dda9d34)
- [FDA Inspection 1223760 - 2023-11-17](https://www.keypedia.com/records/fda_inspections/fougera-pharmaceuticals-inc/5047cfba-3bac-4e83-afac-6b55ffc1b9fc)
- [FDA Inspection 1177371 - 2022-08-10](https://www.keypedia.com/records/fda_inspections/fougera-pharmaceuticals-inc/e71cc3e6-e802-4181-9b0c-1efb5ca83c2d)
- [FDA Inspection 1177371 - 2022-08-10](https://www.keypedia.com/records/fda_inspections/fougera-pharmaceuticals-inc/250bc82a-445c-4c0c-a8f5-bcf602694d6a)

Company: https://www.keypedia.com/companies/fougera-pharmaceuticals-inc/99a927b0-c274-4af7-ab29-2cb4247754c5

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d